Cancer prevention and treatment, particularly lung cancer, remain major healthcare challenges in Taiwan and globally.
This study investigates factors and healthcare utilization patterns associated with adjunctive Chinese herbal medicine (CHM) therapy in non-small cell lung cancer (NSCLC) patients.
